The levels of serum IFN-γ, CXCL9, CXCL10 and the levels of autoantibodies against CXCR3 in the BS patients were higher than control group, and the differences were statistically significant (p < 0.01) (Fig. 1b). The gene discussed is CXCL9; the disease is Bloom syndrome.